Noubar Afeyan said it is at the ‘tail-end’ of COVID booster trials, data expected next week By Kristen Altus Moderna chairman: Omicron threat has to be…
Noubar Afeyan said it is at the ‘tail-end’ of COVID booster trials, data expected next week By Kristen Altus Moderna chairman: Omicron threat has to be…